Operating Income (Loss) in USD of enGene Holdings Inc. from 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
enGene Holdings Inc. quarterly/annual Operating Income (Loss) history and change rate from 2022 to Q2 2025.
  • enGene Holdings Inc. Operating Income (Loss) for the quarter ending July 31, 2025 was -$29.9M, a 78.7% decline year-over-year.
  • enGene Holdings Inc. Operating Income (Loss) for the twelve months ending July 31, 2025 was -$101M, a 82.9% decline year-over-year.
  • enGene Holdings Inc. annual Operating Income (Loss) for 2024 was -$62.3M, a 139% decline from 2023.
  • enGene Holdings Inc. annual Operating Income (Loss) for 2023 was -$26.1M, a 34.1% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

enGene Holdings Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$101M -$29.9M -$13.2M -78.7% May 1, 2025 Jul 31, 2025 10-Q 2025-09-11
Q1 2025 -$88M -$27.1M -$9.81M -56.7% Feb 1, 2025 Apr 30, 2025 10-Q 2025-06-12
Q4 2024 -$78.1M -$26.6M -$15.8M -147% Nov 1, 2024 Jan 31, 2025 10-Q 2025-03-10
Q3 2024 -$62.3M -$17.5M -$7.01M -67.2% Aug 1, 2024 Oct 31, 2024 10-K 2024-12-19
Q2 2024 -$55.3M -$16.8M -$10.5M -168% May 1, 2024 Jul 31, 2024 10-Q 2025-09-11
Q1 2024 -$44.8M -$17.3M -$12.6M -265% Feb 1, 2024 Apr 30, 2024 10-Q 2025-06-12
Q4 2023 -$32.2M -$10.8M -$6.14M -133% Nov 1, 2023 Jan 31, 2024 10-Q 2025-03-10
Q3 2023 -$26.1M -$10.4M Aug 1, 2023 Oct 31, 2023 10-K 2024-12-19
Q2 2023 -$6.25M May 1, 2023 Jul 31, 2023 10-Q 2024-09-10
Q1 2023 -$4.74M Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 -$4.63M Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11

enGene Holdings Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$62.3M -$36.2M -139% Nov 1, 2023 Oct 31, 2024 10-K 2024-12-19
2023 -$26.1M -$6.63M -34.1% Nov 1, 2022 Oct 31, 2023 10-K 2024-12-19
2022 -$19.4M Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.